NCT05749120

Brief Summary

The goal of this clinical trial is to compare the postoperative outcomes based on superficial temporal versus cervical recipient vessels for midface and scalp advanced oncologic defects using free tissue flap for reconstruction. The main question it aims to answer is: • Which recipient vessel is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect. Participants will be undergo resection of advanced malignant tumors of the midface and scalp with subsequent oncological reconstruction using free tissue flap. Researchers will compare two groups where those in whom superficial temporal vessels will be used as the recipient vessels (group A) and those in whom cervical vessels will be used as the recipient vessels (group B) to see if there is a recipient vessel who is most suitable for performing microanastomosis using free flaps for advanced midface and scalp oncologic defect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
Last Updated

March 7, 2023

Status Verified

March 1, 2023

Enrollment Period

4.1 years

First QC Date

February 18, 2023

Last Update Submit

March 3, 2023

Conditions

Keywords

microanastomosisfree tissue flapscervical vesselssuperficial temporal vesselsadvanced reconstruction

Outcome Measures

Primary Outcomes (1)

  • To compare the overall flap survival rate after the microanastomosis

    Adequate perfusion of the free tissue flap was assessed using Doppler flowmetry, flap bleeding time after puncture, color, texture and turgor. Both venous and arterial thrombosis were evaluated by these methods in order to detect whether there was any evidence of low or absence of vascular perfusion of the flap.

    Participants were assessed twice a day for the first 10 days after the intervention and then weekly for 4 weeks.

Study Arms (2)

Superficial temporal recipient vessels (group A)

EXPERIMENTAL

Participants in whom superficial temporal vessels were used as the recipient vessels.

Procedure: Recipient vessel selected for microanastomosis

Cervical recipient vessels (group B)

ACTIVE COMPARATOR

Participants in whom cervical vessels were used as the recipient vessels.

Procedure: Recipient vessel selected for microanastomosis

Interventions

Free tissue flaps harvesting and microanastomosis were performed by the same surgeon and in a similar way in both group. Postoperative course, and complications were recorded and analyzed.

Cervical recipient vessels (group B)Superficial temporal recipient vessels (group A)

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients submitted to subtotal, total, or extensive radical oncologic maxillectomy, or advanced scalp oncologic defect
  • Complete medical records for at least 30 days after the intervention
  • Patients eligible for microanastomosis in both cervical and superficial temporal recipient vessels

You may not qualify if:

  • Pregnancy or breastfeeding;
  • Serious diseases (sepsis, renal and hepatic failure, severe cardiovascular diseases, chronic obstructive pulmonary disease);
  • Patients with HIV (human immunodeficiency virus) with or without AIDS (acquired immunodeficiency syndrome);
  • Patients with synchronous malignant neoplasms of the upper airway-digestive tract;
  • Patients who died within a period of less than 30 days or who were lost to follow-up for the same period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brazilian National Cancer Institute

Rio de Janeiro, 20230130, Brazil

Location

Related Publications (4)

  • Awwad L, Obed D, Vogt PM, Kaltenborn A, Koenneker S. Superficial Temporal Recipient Vessels for Craniofacial Microvascular Free-Flaps. J Craniofac Surg. 2022 Sep 1;33(6):e652-e657. doi: 10.1097/SCS.0000000000008768. Epub 2022 Jul 22.

  • Mata Ribeiro L, Tsao CK, Hung YL, Chu CH, Lin LC, Lin MH, Peng C, Cheong DC, Hung SY, Liao CT. Venous Size Discrepancy Is a Critical Factor When Using Superficial Temporal Vessels as Recipient Vessels for Free Flaps. J Reconstr Microsurg. 2022 Oct;38(8):654-663. doi: 10.1055/s-0042-1743165. Epub 2022 Feb 25.

  • Sudirman SR, Shih HS, Chen JC, Feng KM, Jeng SF. Superficial temporal vessels, both anterograde and retrograde limbs, are viable recipient vessels for recurrent head and neck reconstruction in patients with frozen neck. Head Neck. 2019 Oct;41(10):3618-3623. doi: 10.1002/hed.25886. Epub 2019 Jul 26.

  • Mattine S, Payne KFB. The evolving role of the superficial temporal vessels as anastomotic recipients in challenging microvascular reconstruction of the upper two-thirds of the face. J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3330-3339. doi: 10.1016/j.bjps.2022.04.089. Epub 2022 May 2.

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Bruno A Sousa, MD

    Brazilian National Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The care provider knows the surgical intervention and the randomized participant doesn´t know the recipient vessel performed
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel group trial design with allocation ratio of 1:1 and permuted block randomization
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 18, 2023

First Posted

March 1, 2023

Study Start

April 1, 2018

Primary Completion

April 30, 2022

Study Completion

June 30, 2022

Last Updated

March 7, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations